A detailed history of One River Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, One River Asset Management, LLC holds 2,200 shares of CRSP stock, worth $114,136. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,200
Previous 1,900 15.79%
Holding current value
$114,136
Previous $103 Million 0.72%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$44.62 - $62.75 $20,614 - $28,990
462 New
462 $21.9 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.05B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track One River Asset Management, LLC Portfolio

Follow One River Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One River Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One River Asset Management, LLC with notifications on news.